Century Therapeutics (IPSC) Tax Provisions (2022 - 2024)
Century Therapeutics (IPSC) reported Tax Provisions of $906000.0 for Q4 2024, up 204.62% year-over-year from $297420.8 in Q1 2024, and up 11425.0% quarter-over-quarter from -$8000.0 in Q3 2024.
Century Therapeutics (IPSC) Tax Provisions (2022 - 2024) Analysis & Trends
Century Therapeutics (IPSC) has 3 years of Tax Provisions data on file, last reported at $906000.0 in Q4 2024.
- Tax Provisions for Q4 2024 came in at $906000.0, up 204.62% year-over-year; the trailing twelve-month figure through Dec 2024 was $921000.0 (down 50.91% YoY), and the FY2025 annual result was $5000.0, down 99.46% from the prior year.
- Tax Provisions improved to $906000.0 in Q4 2024 per IPSC's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $1.2 million in Q1 2023 and troughed at -$866000.0 in Q4 2023.
- A 3-year average of $240250.0 and a median of $23500.0 in 2022 frame the typical range for Tax Provisions.
- On a YoY basis, Tax Provisions climbed as much as 7400.0% in 2023 and fell as far as 3307.41% in 2023.
- A 3-year view of Tax Provisions shows it stood at $27000.0 in 2022, then slumped by 3307.41% to -$866000.0 in 2023, then surged by 204.62% to $906000.0 in 2024.
- Business Quant data shows IPSC's Tax Provisions at $906000.0 in Q4 2024, -$8000.0 in Q3 2024, and $22000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 906,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -866,000.00 |
| Sep 30, 2023 | 592,000.00 |
| Jun 30, 2023 | 950,000.00 |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 27,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | 16,000.00 |